ESElena V. Shirshova

Elena V. Shirshova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Elena V. Shirshova has a total of 7 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    CENTRAL PONTINE MYELINOLYSIS: A NEW PERSPECTIVE ON ITS PREVALENCE AND PREVENTION

    by Elena V. Shirshova, Irina V Zakharchuk, Helene O Kontarova, Alexander V Lugovoy, Vladimir P. Baklaushev

    Osmotic demyelination syndrome (ODS) is an acute, localized, symmetric, non‑inflammatory demyelination that affects either the central area of the pontis (central pontine myelinolysis, CPM) or the white matter of the cerebral hemispheres (extrapontine myelinolysis). Demyelination occurs in regions of closest apposition between gray and white matter as a result of cellular edema induced by an abrupt shift in the osmotic gradient, most commonly due to overly rapid correction of chronic hyponatremia. The syndrome may also develop in the setting of other electrolyte and metabolic disturbances, including hypernatremia, hyper‑ or hypochloremia, hypokalemia, malnutrition, intoxication, hyperglycemia, hypertriglyceridemia, use of diuretics or psychoactive drugs, hepatic or renal failure, and other conditions. Before the advent of neuroimaging, ODS was considered rare and was usually diagnosed only at autopsy; however, with the introduction of MRI it has become evident that this syndrome represents a relatively frequent complication in intensive care patients and may account for up to 2.5–5.8% of all cases of electrolyte disturbances, including asymptomatic or pauci‑symptomatic forms. Here we describe a clinical case of CPM in a young woman born in 1987 who, following a period of severe nutritional deficiency, vomiting and subsequent correction of electrolyte disorders, developed dysphagia, dysarthria, tetraparesis and ataxia. The diagnosis was confirmed by MRI, which revealed a characteristic central pontine lesion with a “trident‑shaped” configuration. Intensive treatment and comprehensive rehabilitation resulted in marked regression of neurological deficits with complete functional recovery. This case underscores the need for intensivists and related specialists to remain vigilant regarding the high risk of osmotic demyelination during correction of electrolyte disturbances and to implement timely preventive measures in order to avoid this complication.

  • Open Access

    Affective disorders and сognitive impairment in the early stages of Parkinson’s disease

    by Gulnara Zh. Makhmudova, Niinoya I.N. Vellovich, Elena V. Shirshova

    Background: Parkinson's disease (PD) is an age-related neurodegenerative disease in developed countries. The prevalence of PD ranges from 41 per 100,000 in the fourth decade of life to more than 1,900 per 100,000 in people over 80 years of age. Neurodegeneration associated with Parkinson's disease probably occurs several decades before the onset of motor symptoms. Affective and cognitive impairments are one of the most frequent non-motor manifestations of PD, which can lead to a number of adverse outcomes. Aim: to evaluate affective and cognitive impairments in patients at the early stages of PD. Methods: 61 patients with PD participated in the study. All the participants were divided into two groups depending on the presence or absence of a diagnosis of depression verified by psychiatrists: Group 1 was the main group (n=48), group 2 was the control group (n=13). The control group included patients without depression. The average age of the participants was 62.29.6 years. The analysis of the PD stages was carried out in both groups. In the main group, stage II PD was diagnosed in 75%, in the control group in 31% of patients. The average duration of the disease was 2.51.6 years. A clinical examination was carried out using the Beck depression questionnaire, apathy scale, Spielberger anxiety questionnaire and anxiety assessment scale in PD (to assess emotional disorders), cognitive function assessment scale in PD (SHOBP-Cog, Scopa-Cog), digital symbol replacement test (symbols-numbers test), Montreal assessment Scale cognitive functions (MoCA test), a test for connecting numbers and letters, and a Stroop test (for evaluating cognitive functions). Results: It was revealed that in the early stages of PD, the prevalence of depression, clinically significant apathy, personal and reactive anxiety was high. Significantly higher rates of depression severity, depression level, apathy level and personal anxiety were noted among the patients with stage II PD compared to the patients with stage I PD. There was a marked tendency to a decrease in cognitive functions at stage I of PD, aggravated at stage II of the disease, which was confirmed by the results of the tests: a low level of cognitive functions on the Montreal scale was detected in 52%; 70% of patients, regardless of the PD stage, showed a low rate of completion of the 1st and 2nd parts of the Stroop test for their age; the results of the digital character replacement test were below normal in 75% of cases. Conclusion: The most common affective disorders in the early stages of PD are depression and anxiety. Apathy and depression have a negative impact on the cognitive functions of patients, which worsen with the progression of the disease.


  • Open Access

    Clinical case of Guillain-Barré syndrome associated with COVID-19

    by Elena V. Shirshova, Vladimir V. Knaub, Vladimir P. Baklaushev

    Background: The coronavirus infection caused by SARS-Cov-2 is characterized by a damage to many organs and systems of the human body. To date, convincing information has been obtained about the involvement of various parts of the nervous system in the pathological process in patients with COVID-19. Among the most frequently described impairments, there are disorders of smell and taste, common disorders of the central nervous system, characterized by general cerebral symptoms, such as headache, asthenization, psychopathological disorders. One of the rare and severe forms of the peripheral nervous system damage in COVID-19 is Guillain-Barre syndrome (GBS), characterized by acute post-infectious inflammatory polyneuropathy with an autoimmune etiology. Clinical case description. We present a clinical case of GBS associated with COVID-19. The disease debuted as a peripheral tetraparesis with a progredient course of up to 21 days. Systemic administration of immunoglobulin stopped the disease progression. The association of GBS with COVID-19 was clarified a month after the disease onset, when bilateral polysegmental pneumonia was diagnosed, and a high level of IgG to the S-protein of SARS-CoV-2 was found, 3 times higher than the level of IgM, which indicated the duration of the disease was not less than three weeks. Conclusion: The GBS development upon infection with SARS-CoV-2 may precede the lung damage. The debut of GBS during the COVID-19 pandemic requires the exclusion of the SARS-CoV-2 etiological role in each case.